Evaluating the Role of Aspirin in Liver Disease: Efficacy, Safety, Potential Benefits and Risks by Amani Elshaer, Blanca C. Lizaola-Mayo

Subjects: Get full text

Risk stratification by noninvasive tests in patients with metabolic dysfunction-associated steatotic liver disease by Hye Won Lee, Jae Seung Lee, Mi Na Kim, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim

Subjects: “…metabolic-associated steatotic liver disease…”
Get full text

New approaches to diagnosis and management of patients with metabolic-associated steatotic liver disease with immune response to SARS-CоV-2 by V.I. Didenko, S.L. Melanich, I.A. Klenina, O.M. Tatarchuk, O.P. Petishko, H.I. Bocharov

Subjects: “…metabolic-associated steatotic liver disease…”
Get full text

GCKR Polymorphisms Increase the Risks of Low Bone Mineral Density in Young and Non‐Obese Patients With MASLD and Hyperuricemia by Tzu‐Hao Li, Yu‐Shin Huang, Chia‐Chen Ma, Shin‐Yu Tsai, Hung‐Cheng Tsai, Hsiao‐Yun Yeh, Hsiao‐Chin Shen, Shiao‐Ya Hong, Chien‐Wei Su, Hwai‐I Yang, Ying‐Ying Yang, Ming‐Chih Hou

Subjects: Get full text

Artificial Intelligence and Image Analysis-Assisted Diagnosis for Fibrosis Stage of Metabolic Dysfunction-Associated Steatotic Liver Disease Using Ultrasonography: A Pilot Study by Itsuki Fujii, Naoki Matsumoto, Masahiro Ogawa, Aya Konishi, Masahiro Kaneko, Yukinobu Watanabe, Ryota Masuzaki, Hirofumi Kogure, Norihiro Koizumi, Masahiko Sugitani

Subjects: Get full text

Liver macrophage activation: Relation with hepatic histopathological changes in patients with metabolic associated steatotic liver disease by Doaa H. Hegazy, Fathalla S. Mohamed, Sabah A. H. Mahmoud, Nevine M. F. El Deeb, Amany Elyamany, Ahmed M. Elgendi

Subjects: “…metabolic associated steatotic liver disease…”
Get full text

Identifying disease progression biomarkers in metabolic associated steatotic liver disease (MASLD) through weighted gene co-expression network analysis and machine learning by Weiliang Zhang, Weirong Lu, Yaqi Jiao, Tianhao Li, Haining Wang, Chunhua Wan

Subjects: “…Metabolic associated steatotic liver disease…”
Get full text

Hepatic fibrosis in morbidly obese patients: fibroscan accuracy by Maged Tharwat Elghannam, Moataz Hassan Hassanien, Ahmed Aly ELRay, Hoda Mohamed Abu-Taleb, Yosry Abdelrahman Ameen, Gamal Mohammed ELattar, Emad Abdelwahab Turky, Mohammed Darwish ELTalkawy

Subjects: “…metabolic associated steatotic liver disease…”
Get full text

Efficacy of liraglutide in patients with metabolic-associated steatotic liver disease in type 2 diabetes mellitus by Yu.M. Stepanov, O.V. Zinych, I.A. Klenina, K.O. Shyshkan-Shyshova, N.M. Kushnarоva

Subjects: “…metabolic-associated steatotic liver disease…”
Get full text

Effect of treadmill walking on cardiometabolic risk factors and liver function markers in older adults with MASLD: a randomized controlled trial by Jiyoun Kim, Sungju Lee, Yong-Seok Jee

Subjects: Get full text

Metabolic associated steatotic liver disease misses fewer high-risk patients than metabolic associated fatty liver disease by Yu-Ming Cheng, Tsung-Han Hsieh, Shan-Wen Wang, Chia-Chi Wang, Jia-Horng Kao

Subjects: Get full text

Prevalence of metabolically associated steatotic liver disease in the elderly: analysis and perspectives by O. O. Karshina

Subjects: “…metabolically associated steatotic liver disease…”
Get full text